AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
LONDON: AstraZeneca‘s COVID-19 vaccine, Vaxzevria, formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals aged 18...
COVID-19 Vaccine AstraZeneca authorised for use in the EU
LONDON: AstraZeneca‘s COVID-19 vaccine has been granted a conditional marketing authorisation (CMA) in the European Union (EU) for active immunisation to prevent COVID-19 caused by...
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine
LONDON: Sanofi and have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses of...
Moderna expands BARDA agreement to support COVID-19 vaccine program
CAMBRIDGE: Moderna Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,...